These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7827760)

  • 21. Alpha-1 antitrypsin: now available, but do we need it?
    Russi EW
    Swiss Med Wkly; 2008 Apr; 138(13-14):191-6. PubMed ID: 18389391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group.
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Eur Respir J; 1998 Feb; 11(2):428-33. PubMed ID: 9551749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of biweekly α
    Greulich T; Chlumsky J; Wencker M; Vit O; Fries M; Chung T; Shebl A; Vogelmeier C; Chapman KR; McElvaney NG;
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30237305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha 1-antitrypsin deficiency.
    Ellett ML
    Gastroenterol Nurs; 1991 Dec; 14(3):138-41. PubMed ID: 1760450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin.
    Stoller JK; Rouhani F; Brantly M; Shahin S; Dweik RA; Stocks JM; Clausen J; Campbell E; Norton F
    Chest; 2002 Jul; 122(1):66-74. PubMed ID: 12114340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics of alpha1-antitrypsin replacement therapy in severe congenital emphysema].
    Vidal Pla R; Padullés Zamora N; Sala Piñol F; Jardí Margaleff R; Rodríguez Frías F; Montoro Ronsano JB
    Arch Bronconeumol; 2006 Oct; 42(10):553-6. PubMed ID: 17067523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new variant of alpha-1-antitrypsin deficiency (Siiyama) associated with pulmonary emphysema.
    Takabe K; Seyama K; Shinada H; Nouchi T; Miyahara Y; Nukiwa T; Miyake K; Tsukimoto K; Ichioka M; Marumo F
    Intern Med; 1992 May; 31(5):702-7. PubMed ID: 1504439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous alpha-1-antitrypsin replacement therapy: case report after one year of treatment.
    Ward AC; Keogh BA
    Ir J Med Sci; 1997; 166(1):7-9. PubMed ID: 9057422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.
    Krotova K; Marek GW; Wang RL; Aslanidi G; Hoffman BE; Khodayari N; Rouhani FN; Brantly ML
    Am J Respir Cell Mol Biol; 2017 Aug; 57(2):238-247. PubMed ID: 28362108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.
    Piitulainen E; Bernspång E; Björkman S; Berntorp E
    Eur J Clin Pharmacol; 2003 Jun; 59(2):151-6. PubMed ID: 12728289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Characteristics of the patients included in the French cohort of patients with emphysema caused by alpha-1 antitrypsin deficiency].
    Thabut G; Mornex JF; Cuvelier A; Padrazzi B; Pison C; Neukirch F; Lafitte JJ; Boczkowski J; Balduyck M; Muir JF; Carles P; Fournier M
    Rev Mal Respir; 2008 Nov; 25(9):1115-22. PubMed ID: 19106908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society.
    Abboud RT; Ford GT; Chapman KR;
    Can Respir J; 2001; 8(2):81-8. PubMed ID: 11320399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency.
    Tirado-Conde G; Lara B; Miravitlles M
    Ther Adv Respir Dis; 2008 Feb; 2(1):13-21. PubMed ID: 19124355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route.
    Hubbard RC; Crystal RG
    Lung; 1990; 168 Suppl():565-78. PubMed ID: 2117165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Longterm Homecare Augmentation Program in Alpha-1-Antitrypsin Deficient Patients].
    Wilke A; Semper H; Gross C; Grohé C
    Pneumologie; 2018 Aug; 72(8):590-597. PubMed ID: 30089330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex-specific differences in emphysema using a murine antisense oligonucleotide model of α-1 antitrypsin deficiency.
    Joshi R; Ojha M; Lewis J; Fan Q; Monia B; Guo S; Varisco BM
    Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1165-L1173. PubMed ID: 31017014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency.
    Stoller JK; Gildea TR; Ries AL; Meli YM; Karafa MT;
    Ann Thorac Surg; 2007 Jan; 83(1):241-51. PubMed ID: 17184672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy.
    Dirksen A; Dijkman JH; Madsen F; Stoel B; Hutchison DC; Ulrik CS; Skovgaard LT; Kok-Jensen A; Rudolphus A; Seersholm N; Vrooman HA; Reiber JH; Hansen NC; Heckscher T; Viskum K; Stolk J
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1468-72. PubMed ID: 10556107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
    Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
    Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency.
    Stockley RA; Bayley DL; Unsal I; Dowson LJ
    Am J Respir Crit Care Med; 2002 Jun; 165(11):1494-8. PubMed ID: 12045122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.